P3 Health Partners INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
P3 Health Partners is holding its annual stockholder meeting on June 4, 2025, to vote on key proposals including the election of directors, ratification of the independent auditor, approval of executive compensation, and the issuance of shares upon warrant exercises.
NASDAQ
DEF: P3 Health Partners Seeks Stockholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
P3 Health Partners is asking stockholders to approve a reverse stock split to boost its stock price and maintain its Nasdaq listing.
NASDAQ
P3 Health Partners announces Aric Coffman as the new CEO, succeeding Sherif Abdou, who transitions to Vice Chairperson and Senior Advisor.
NASDAQ
P3 Health Partners Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
P3 Health Partners Inc. will hold its annual stockholder meeting virtually on June 6, 2024, to vote on director elections, auditor ratification, executive compensation, and other matters.